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Cre/loxPPax6 is a highly conserved transcription factor that controls the morphogenesis of various organs. Changes in
Pax6 dosage have been shown to affect the formation of multiple tissues. PAX6 haploinsufﬁciency leads to
aniridia, a pan-ocular disease primarily characterized by iris hypoplasia. Herein, we employ a modular system
that includes null and overexpressed conditional alleles of Pax6. The use of the Tyrp2-Cre line, active in iris
and ciliary body (CB) primordium, enabled us to investigate the effect of varying dosages of Pax6 on the
development of these ocular sub-organs. Our ﬁndings show that a lack of Pax6 in these regions leads to
dysgenesis of the iris and CB, while heterozygosity impedes growth of the iris and maturation of the iris
sphincter. Overexpression of the canonical, but not the alternative splice variant of Pax6 results in severe
structural aberrations of the CB and hyperplasia of the iris sphincter. A splice variant-speciﬁc rescue
experiment revealed that both splice variants are able to correct iris hypoplasia, while only the canonical
form rescues the sphincter. Overall, these ﬁndings demonstrate the dosage-sensitive roles of Pax6 in the
formation of both the CB and the iris.© 2009 Elsevier Inc. All rights reserved.Introduction
Organ master regulators are genes that are responsible for the
initial commitment of a pluripotent tissue to a particular fate. We now
know that besides this fundamental role, such genes can be utilized at
later stages for additional functions in the forming tissues. This
concept goes along with the genomic data indicating that the actual
number of genes is somewhat smaller than initially believed.
Pax6 is an excellent example of a master regulator. This member of
the PAX family of transcription factors is highly conserved among
metazoans, and is both necessary and sufﬁcient for eye formation in
vertebrate and invertebrate species (Chow et al., 1999; Gehring, 2002;
Grindley et al., 1995; Halder et al., 1995; Kozmik, 2005; Quiring et al.,
1994). Moreover, widespread ocular expression during late stages of
eye development implicates later roles for Pax6 in the differentiation
and maintenance of distinct ocular cell types (Walther and Gruss,
1991). The aim of this study was to decipher the dosage requirements
for Pax6 in the formation of the iris and ciliary body (CB), accessory
sub-organs of the eye that play important roles in visual function
(reviewed in Beebe (1986); Davis-Silberman and Ashery-Padandan).
l rights reserved.(2008); Napier and Kidson (2007)). The lens is attached to the CB
by suspensory ligaments; contractions of the ciliary muscle alter lens
shape and allow accommodation. In addition, the epithelial layers of
the CB secrete aqueous and vitreous humors, which generate
intraocular pressure (IOP). The iris mainly regulates the amount of
light entering the eye by mydriasis and miosis of the pupil.
The iris and CB develop from themargins of the optic cup (OC). The
inner layer of the OC gives rise to the neuroretina, the outer layer to
the underlying retinal pigmented epithelium (RPE) and the marginal
zone to the eye's anterior structures — the iris and CB. During
embryogenesis and early postnatal stages, the margins of the OC
extend and differentiate into the iris and CB epithelia and into the
smooth muscles of the iris, the sphincter and the dilator. Migratory
periocular mesenchymal cells adhere to the iris and CB primordium
and create an associated stroma (Smith et al., 2002).
Pax6 is expressed in the iris and CB throughout their development
and maturity. At ﬁrst, Pax6 is uniformly expressed across the OC
(Walther and Gruss, 1991). At around mid-gestation, a proximallow–
distalhigh gradient in the protein level is established within the optic
cup, with lower expression in the proximity of the optic nerve and
higher expression in the distal tips of the optic cup. At this stage, Pax6
expression in the proximal RPE is downregulated (Baumer et al., 2002;
Walther and Gruss, 1991). Pax6 levels are highest in the non-neuronal
133N. Davis et al. / Developmental Biology 333 (2009) 132–142progenitor pool, destined for an iris and CB fate (Davis-Silberman et
al., 2005). Pax6 expression persists in the iris and CB progenitors,
probably functioning in their differentiation and speciﬁcation. In
adults, Pax6 is expressed in the iris musculature and in the epithelial
layer of both the iris and CB, and it is required for the stem cell
properties of the pigmented layer of the CB (Xu et al., 2007).
Interestingly, the correct levels of Pax6 expression are essential for
proper development of the eye, particularly of the iris. Mutations in
human PAX6 lead to aniridia, a pan-ocular dominantly inherited
disease, associated primarily with iris hypoplasia (Glaser et al., 1994;
Jordan et al., 1992). Other features of aniridia include corneal opacity,
cataract formation, foveal dysplasia and late-onset glaucoma (Elsas et
al., 1977; Guercio and Martyn, 2007; Rush, 1926). The Small-eye
condition in mice and rats (Sey), caused by heterozygosity for
mutations in Pax6, constitutes an animal model that closely resembles
human aniridia (Baulmann et al., 2002). Interestingly, overexpression
of Pax6 in mice also causes ocular defects, including microphthalmia,
microcornea, iris and CB cysts, cataracts and retinal abnormalities
(Manuel et al., 2008; Schedl et al., 1996).
To investigate the tissue speciﬁc roles of Pax6 within the anterior
eye structures, we previously employed the Cre/loxP approach to
inactivate one allele of Pax6 in the OC (Davis-Silberman et al., 2005).
This local reduction in Pax6 dosage interrupts iris development in
several ways: ﬁrst, it leads to a signiﬁcant decrease in the size of the
iris progenitor pool; second, it causes a delay in the expression of
muscle-speciﬁc markers, and ﬁnally, it impedes the morphogenesis of
the sphincter muscle and the stroma (Davis-Silberman et al., 2005).
In vertebrates, Pax6 has two major splice variants that differ in the
structure of their paired domain, due to an alternative insertion of
42 bp between exons 5 and 6. This alternative splice variant,
designated Pax6-5a, exhibits unique DNA-binding properties and
probably regulates a different set of downstream targets (Chauhan et
al., 2004b; Kozmik et al., 1997). Unlike other Pax domains that interact
through the amino terminus (“PAI”) of the paired domain, Pax6-5a
binds to DNA through the carboxyl terminus (“RED”) (Chauhan et al.,
2002; Kozmik et al., 1997). Based on this property, it has been
suggested that Pax6-5a is related to Eyegone, one of the Pax6 paralogs
in Drosophila, which also binds to DNA through the RED half-domain
and recognizes the same consensus DNA-binding site (Dominguez et
al., 2004).
As been noted above, Pax6 proteins are widely expressed
throughout the eye. Most of the data, nevertheless, does not
distinguish between the speciﬁc expression patterns of the different
splice variants. Few studies, performed on a variety of organisms, did
took the alternative splicing into consideration and demonstrated that
both proteins are expressed in the brain (Pinson et al., 2005) and in
the ocular system, including the lens, iris, cornea and retina (Azuma et
al., 2005; Jaworski et al., 1997). Within the retina, Pax6-5a was found
to be restricted to an area between the optic nerve head and the fovea
in marmosets (Azuma et al., 2005). RT-PCR performed on bovine eye
demonstrated that the ratio between the two splice variants varies
within different eye parts, with preference of the lens to the canonical
form while the iris yields higher levels of the alternative variant
(Azuma et al., 2005; Jaworski et al., 1997). In primate lens, cornea and
macula, nevertheless, both proteins were found in similar proportion
(Zhang et al., 2001). Finally, the correct ratio between the two
transcripts has been shown to be essential for the proper regulation of
speciﬁc targets, such as some of the lens crystallins (Chauhan et al.,
2004a).
The deletion of exon 5a in e5a/e5a mice leads to an ocular
phenotype that includes defects in the iris, cornea, lens and retina
(Singh et al., 2002). Moreover, there is a clear requirement for correct
Pax6-5a dosage, as e5a/+mice display iris hypoplasia, whereas lens-
speciﬁc overexpression of Pax6-5a leads to cataracts (Duncan et al.,
2000). In humans, heterozygous missense mutations within exon 5a
lead to a variety of ocular phenotypes, including Peters' anomaly,Axenfeld's anomaly, congenital cataracts and foveal hypoplasia
(Azuma et al., 1999; Epstein et al., 1994).
Here, we studied the sensitivity of the CB and iris to changing
dosages of Pax6. A complete absence of Pax6 precludes the formation
of both organs, while haploinsufﬁciency leads to a milder phenotype
of the iris but does not affect the CB. The canonical splice variant of
Pax6 was found to be more potent than the alternative in correcting
this phenotype, and upon overexpression leads to CB defects. Overall,
this study exposes the late and splices variant-speciﬁc roles of Pax6 in
the development of the iris and CB and expands our knowledge on the
phenomenon of Pax6 dosage sensitivity.
Material and methods
Mice
Pax6ﬂox/ﬂox, Z/AP, JoP6 and JoP6-5amouse lines were established as
described previously (Ashery-Padan et al., 2000; Berger et al., 2007;
Lobe et al., 1999) (Figs. 1A and 4A). The Tyrp2-Cre transgene contains
regulatory sequences of tyrosinase-related protein-2 (Tyrp2)
(−754 bp upstream to +194 bp downstream of the transcription
start codon) followed by the coding sequence of the Cre recombinase
gene (Fig. 1B).
Genotypingwas performed by PCRusing the following forward and
reverse primers: Cre 5′-ATGCTTCTGTCCGTTTGCCG-3′, 5′-CCTGTTTT-
GCACGTTCACCG-3′, Tm=57 °C; Flox 5′-GCGGTTGAGTAGCT-
CAATTCTA-3′, 5′-AGTGGCTTGGACTCCTCAAGA-3, Tm=58 °C; LacZ
(for genotyping of the JoP and Z/AP mice) 5′-CGTCACACTACGTCT-
GAACGTCG-3′, 5′-CAGACGATTCATTGCCACCATGC-3′, Tm=65 °C. The
genetic backgrounds were: ICR for Z/APmice; C57BL6J for Pax6ﬂox/ﬂox
mice, and either C57BL6J or mixed ICR/C57BL6J for Tyrp2-Cremice.
Pupil constriction, histology and EM
The day onwhich the copulatory plug was observedwas deﬁned as
embryonic day (E) 0.5, and the day of birthwas referred to as postnatal
day (P)1. For pupil constriction, the enucleated eyeswere incubated for
7 min in 4% pilocarpine (Sigma) in 0.9% NaCl. Eyes and embryos were
photographed using an MZFLIII ﬂuorescent stereomicroscope.
Specimens were ﬁxed overnight in 4% paraformaldehyde and
embedded in parafﬁn, according to standard protocols. For semithin
sectioning, eyes were ﬁxed overnight in 0.1% cacodylate-buffered
ﬁxative containing 2.5% paraformaldehyde and 2.5% glutaraldehyde
and embedded in Epon (Roth, Karlsruhe, Germany). For scanning
electron microscopy (SEM), eyes were ﬁxed overnight in 0.1%
cacodylate-buffered ﬁxative containing 2.5% paraformaldehyde and
2.5% glutaraldehyde. After 30 min incubation in 1% osmium tetroxide
and dehydration in ascending ethanol and acetone series, specimens
were critical-point dried, sputter-coated with gold and examined
under a JSM 840A scanning electron microscope (JEOL). For
histological staining, 10-μm parafﬁn sections were stained with
hematoxylin-eosin and 1-μm semithin sections were stained with
toluidine blue, according to standard protocols.
Immunoﬂuorescence analysis, β-galactosidase staining and
TUNEL assays
For immunoﬂuorescence analysis, 10-μm parafﬁn sections were
stained as previously described (Ashery-Padan et al., 2000). Primary
antibodies used were αPax6 (1:1000, Chemicon), αSma (α smooth
muscle actin, 1:250, Sigma), αCaveolin3 (1:100, Santa Cruz), αhAP
(human alkaline phosphatase, 1:100, Santa Cruz), αVC1.1 (1:500,
Sigma), αPhospho-histone3 (1:500, Santa Cruz) and αCyclinD1
(1:250, Thermo Scientiﬁc). For all antibodies but αSma, sections
were boiled twice in unmasking solution (Vector) prior to blocking.
Secondary antibodies were conjugated to rhodamine red-X or to Cy2
Fig. 1. Transgenic lines for somatic inactivation of a single Pax6 allele. (A) Schematic representation of the Pax6 ﬂoxed allele (Pax6ﬂox). Exons are shown in boxes, Pax6 transcription
initiation start sites are marked by arrows and the loxP sites are represented by arrowheads. (B) The Tyrp2-Cre transgene includes 949 bp of the Tyrp2 promoter followed by the Cre
recombinase sequence, an intron and a poly A tail. (C) The Z/AP transgene contains the β-actin promoter and the CMV enhancer (CAAG), the LacZ reporter gene ﬂanked by loxP
sequences followed by the human alkaline phosphatase (hAP) gene. (D) Whole-mount hAP staining of E9.5 embryo shows Cre activity in the forebrain, dorsal root ganglia and the
eye. (E) Positive staining is apparent in the RPE of E11.5 Tyrp2-Cre;Z/AP embryos and in the dorsal margins of the retina. The anterior progenitor pool is marked by an arrowhead. (F)
At E13.5, hAP activity spreads to the ventral part of both RPE and OC margins. The perinatal (G) and postnatal (H–J) iris and CB are strongly stained, including the pigmented
epithelium of both structures, the iris musculature and stroma. Panels I and J are higher magniﬁcations of the corresponding areas in panel H. (H–J) Immunoﬂuorescent staining
shows co-localization of hAP and Pax6 in the pigmented epithelium of the iris and CB and in the iris musculature. Abbreviations: ciliary body, CB; dilator, D; dorsal root ganglia, DRG;
dorsal/ventral pigmented epithelium, d/vRPE; forebrain, fb; iris muscles, IM; iris pigmented epithelium, IPE; iris stroma, IS; lens, le; neuroretina, nr; non-pigmented ciliary
epithelium, NPCE; pigmented ciliary epithelium, PCE; sphincter, S. Scale bar=100 μm.
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Olympus BX61 ﬂuorescent microscope and images were analyzed
using the image analysis system ‘AnalySIS’ (Soft Imaging Analysis).
TUNEL assay was performed using the In Situ Cell Death Detection
kit (Roche), according to manufacturer's instructions. Alkaline
phosphatase (AP) staining was performed on albinomice as described
previously (Lobe et al., 1999). β-galactosidase whole-mount staining
was performed on albino mice as described previously (St-Onge et al.,
1997).
Morphometric analysis
To obtain position-matched sections of embryonic eyes, whole
heads were embedded at a known orientation and transverse serial
sections of the eyes were collected. For postnatal stages, eyes were
positioned in parallel to the optic nerve. Measurements were
conducted on central sections that included the pupil. To
determine the degree of iris hypoplasia we measured iris length,
deﬁned as the distance between the iris root and the margins of
the pupil. To avoid postmortem changes on muscle contractions, all
measurements were performed on eyes that were treated with
pilocarpine (see “Pupil constriction, histology and EM” section). For
measurements of adult eye sizes, enucleated eyes were photo-
graphed using an MZFLIII ﬂuorescent stereomicroscope (Leica) and
their diameter was determined. The area of retina, the length of
the RPE and the diameter of the lens were measured on centralparafﬁn sections that included the lens and were stained with
hematoxylin-eosin. All images were analyzed using the image
analysis system ‘AnalySIS’. Results were averaged for each eye and
then for each genotype. Values are presented as percentage of wild
type±standard error. Either Student's t-test or Mann–Whitney
non-parametric test was used to determine statistical signiﬁcance.
Evaluation of Pax6 levels in Tyrp2-Cre;JoP6 and Tyrp2-Cre;JoP6-5a
was performed by measuring pixel intensity of Pax6 immuno-
ﬂuorescence as described previously (Davis-Silberman et al., 2005).
Brieﬂy, pixel intensity was measured in cells of adult pigmented CB
using the image analysis system ‘AnalySIS’. The values were
normalized by dividing them by Pax6 pixel averaged intensity in
the ganglion cell layer of the proximal retina, which are not
mutated in these transgenic mice.
Results
Pax6 is required in the non-neuronal progenitors of the OC for iris and
CB formation
Previous phenotypic analysis of Pax6ﬂox/+;a-Cremutants, in which
one allele of Pax6 was inactivated in the distal retina from E10.5 and
on, revealed that a normal dosage of the protein is required for normal
differentiation of the iris (Davis-Silberman et al., 2005). Whether this
requirement was directly related to Pax6 expression levels in the
developing iris was not resolved in that study, as the α-Cre transgene
135N. Davis et al. / Developmental Biology 333 (2009) 132–142is active in both the neuronal and non-neuronal progenitors of the
OC (Marquardt et al., 2001).
To inactivate a single allele in the non-neuronal progenitors but not
in the adjacent retinal progenitor cells, we established the Tyrp2-Cre
transgenic mouse line. The Tyrp2-Cre transgene contains 949 bp of the
tyrosinase-related protein-2 (Tyrp2) regulatory sequences, followed
by the Cre recombinase gene (Materials and methods and Fig. 1B).
This regulatory region is highly conserved among vertebrate species
and is part of a 1.7-kb fragment employed previously to regulate LacZ
reporter activity in a pattern that mimics Tyrp2 gene expression (ZhaoFig. 2. Pax6 expression within the RPE and retinal margins is essential for the formation o
pilocarpine, (D–O) semithin sections stained with toluidine blue. Pax6ﬂox/ﬂox;Tyrp2-Cre homo
the iris and CB (B, E and enlargement in panels H and K). The Pax6ﬂox/ﬂox;Tyrp2-Cre lens is d
Cre;Pax6ﬂox/+ heterozygote mice (C, F, I, L, O) exhibit severe hypoplasia of the iris (C, F, and en
in control iris, G). The ciliary body (L) and the lens (O) appear normal in heterozygotes. Abbr
(G–I, M–O)=100 μm, (J–L)=20 μm.et al., 2002). To characterize the recombination pattern, we employed
the Z/AP reporter line, in which Cre-mediated recombination results
in hAP activity (Fig. 1C (Lobe et al., 1999)). In the double-transgenic
Tyrp2-Cre;Z/AP mice, hAP was detected in the eye, forebrain and
dorsal root ganglia from E9.5 (Fig. 1D), corresponding with the
reported pattern of the Tyrp2-LacZ transgene (Zhao et al., 2002). In
E11.5 embryos, hAP activity encompassed the dorsal RPE while in the
ventral RPE hAP activity was patchy (Fig. 1E), in agreement with the
gradual expression of Tyrp2 in the developing RPE (Zhao et al., 2002).
At a subsequent stage (E13.5), most cells of the RPE expressed hAP inf the anterior structures and lens. (A–C) Irises of adult eyes following treatment with
zygote eyes (B, E, H, K, N) are smaller and are almost devoid of the anterior structures of
istorted, cataractic and contains sub-capsular clusters of mesenchymal cells (N). Tyrp2-
largement in I) with marked atrophy of the sphincter muscle (marked with arrowhead
eviations: ciliary body, CB; iris, ir; lens, le; toluidine blue, TB. Scales bar: (A–F)=1 mm,
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structures of the CB and iris (Fig. 1F). A few days later (E17.5),
expression of the transgene appeared in the newly forming muscle
cells (Fig. 1H). This result is surprising as the Tyrp2 promoter is usually
active in melanocytes and not in muscle cell type; nevertheless, the
iris muscles are derived from the OC epithelium which possibly
explains the unexpected expression within them. Examination of
perinatal (Fig. 1G) and postnatal (Figs. 1I–K) Tyrp2-Cre;Z/AP mouse
eyes revealed intense expression of hAP in the pigmented epithelium
of the CB and iris (Figs. 1J, K), and in the iris musculature and stroma
(Fig. 1K). Pax6 and hAP were co-localized in the Tyrp2-Cre;Z/APmice,
except in the iris stromawhich is devoid of Pax6 expression, and in the
CB non-pigmented epithelium that showed only occasional, patchy
labeling of hAP (Figs.1I–K). Taken together, the recombination pattern
mediated by the Tyrp2-Cre transgene corresponds with a previous
report on the activity of the 1.7-kb regulatory sequence of the Tyrp2
gene (Zhao et al., 2002), and suggests that the 949 bp contain the
regulatory elements that are required for the expression pattern of
Tyrp2 in the developing eye.
To study the phenotype upon ablation of Pax6 from iris and CB
progenitors, we characterized the phenotype of Pax6ﬂox/ﬂox;Tyrp2-Cre
mice (Fig. 1A). Mutant eyes were smaller than normal (Fig. 2B).
Smaller retina, RPE and lens were evident as early as E15.5 (Fig. S1).
The iris was almost entirely absent, with only residual thin strands
covering the anterior surface of the lens (Fig. 2B). Sagittal sectioning
demonstrated the persistence of a short iris stump with a complete
lack of CB structure (Figs. 2E, H, K). The Pax6ﬂox/ﬂox;Tyrp2-Cre lens wasFig. 3. Iris postnatal development is disrupted in Pax6ﬂox/+;Tyrp2-Cremice. (A–F) View of iri
with antibodies against alpha-smooth muscle actin (αSma) or (H, K) Caveolin3 (Cav-3). Ins
was detected in Pax6ﬂox/+;Tyrp2-Cre eyes as early as P4 (D–F'). In contrast to normal irises
irises (D'–F') displayed growth arrest and remained remarkably short. In addition, pupillary r
was detected in both Pax6ﬂox/+;Tyrp2-Cre (D'–F', J) and control eyes (A'–C',G), but it was nega
pigmented irises, demonstrating sphincter atrophy in Pax6ﬂox/+;Tyrp2-Cre mice (arrowhead
ciliary body, CB; iris, ir; lens, le. Scale bar: (A–F)=500 μm, (A'–F')=100 μm, (G–J)=25 μmopaque, its lentoidmorphology distorted andmesenchymal cells were
aberrantly populating the anterior chamber (Fig. 2N). The vitreous
body was not transparent and in some eyes seemed to protrude into
the anterior chamber. These ﬁndings reinforce the notion that Pax6 is
fundamental for formation of the CB and iris and that this function is
autonomous to the progenitors of these structures. Furthermore,
normal development of the iris and CB appears to be indirectly
essential for the organization of other components of the eye, such as
the lens and vitreous body.
Pax6ﬂox/+;Tyrp2-Cre heterozygote eyes exhibited profound iris
hypoplasia with marked atrophy of the sphincter muscle (Figs. 2C, F,
I). In contrast to homozygote eyes, the CB and lens appeared normal
(Figs. 2L, O). These experiments reﬁne the cellular basis of the
anterior eye phenotype seen in both Pax6+/− mice (i.e. carriers of
the complete knockout allele) and Pax6ﬂox/+;a-Cre conditional
mutants where both neuronal and non-neuronal progenitors were
mutated (Davis-Silberman et al., 2005).
Sphincter muscle and pupillary ruffs are perturbed upon somatic
reduction of Pax6 dosage in iris progenitors
To elucidate the etiology of the iridial phenotype of Pax6ﬂox/+;
Tyrp2-Cre mice, we conducted a thorough analysis of iris differentia-
tion in control (Figs. 3A–C') and Pax6-heterozygote eyes (Figs. 3D-F').
During the ﬁrst 2 weeks after birth, the iris anlage normally
elongates toward the center of the lens (Figs. 3A–C'). This process is
accompanied by differentiation of the various iris layers, includingses of P4–P15 eyes treated with pilocarpine and (A'–F', G, I, J, L) parafﬁn sections labeled
ets in panels A'–C' and D'–F' are higher magniﬁcations of the boxed area. Iris hypoplasia
(A'–C') that elongate at these stages toward the center of the lens, Pax6ﬂox/+;Tyrp2-Cre
affs weremissing (insets in panels C and F). Iris musculature (labeled in green forαSma)
tive for the sphincter-speciﬁc marker Caveolin3 in the mutants (K). (I, L) Images of non-
). The appearance of the dilator muscle (double arrowhead) is normal. Abbreviations:
.
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2004; Imaizumi and Kuwabara, 1971)). The muscle-progenitor cells,
located at the iris tip, are ﬁrst recognized by expression of the
smooth-muscle-speciﬁc marker αSma (Fig. 3G). At around P8, these
cells start to express the sphincter-speciﬁc marker Caveolin3 (Fig.
3H). A few days later, in concordance with the opening of the eyes,
the sphincter begins to react to the parasympathetic agonist
pilocarpine that functions to constrict the sphincter muscle and
thus to close the pupil.
This developmental sequence is disrupted when Pax6 dosage is
reduced in the Pax6ﬂox/+;Tyrp2-Cre mice. First, the mutant iris fails to
elongate, resulting in a markedly enlarged pupil (Figs. 3D–F). Second,
the margins of the mutant pupil are abnormally smooth, indicating a
lack of pupillary ruffs (insets of Figs. 3C and F). Finally, despite
expression of the smooth-muscle-speciﬁc marker αSma (Figs. 3D'–F'
and J, L), the sphincter muscle does not develop properly and
eventually lacks its typical structure. To further validate loss of the
sphincter muscle, we characterized the expression of Caveolin3,
which is speciﬁcally expressed in the sphincter but not in the dilator
muscle (Kogo et al., 2006) (Fig. 3H). Caveolin3 was not detected in the
Pax6ﬂox/+;Tyrp2-Cre mutants (Fig. 3K). Moreover, as expected from
the loss of the sphincter, the Pax6ﬂox/+;Tyrp2-Cre iris did not respond
to pilocarpine (data not shown). Interestingly, the effect of Pax6
haploinsufﬁciency was conﬁned to the sphincter and not to the dilator
muscle, which appeared to be largely normal based on αSma
expression and histological analysis (Fig. 3L). The latter notion should
be considered with care, due to the lack of dilator-speciﬁc antibodies.
Taken together, we suggest that in addition to Pax6's role in iris
growth, this gene has a novel and dosage-sensitive role in myogenesis
of the iris sphincter.Fig. 4. Scheme and activity of the JoP6 transgenes. (A) JoP transgenes include the CMV enhanc
can or Pax6-5a coding sequence. Cre-mediated recombination eliminates the GFP sequenc
expression in E12.5 JoP6-5a (B) and JoP6 (F) embryos. (C, G) are images of whole-mount β
demonstrating restricted recombined areas in the brain and eyes. (D, H) are eye sections of pan
in the retinal margins. (E, I) are images of whole-mount β-galactosidase staining of P4 Tyrp
presumptive iris and CB. Abbreviations: lens, le; neuroretina, nr; retinal pigmented epitheliuOverexpression of the canonical form of Pax6 leads to maldevelopment
of the CB and hyperplasia of the iris sphincter
The sensitivity of the iris to a reduction in Pax6 expression raised
the question of whether the iris would be sensitive to an elevation in
Pax6 dosage as well. Studies on human carriers of chromosomal
duplications and on transgenic mice have suggested that over-
expression of PAX6/Pax6 can result in a variety of ocular phenotypes,
including iris abnormalities (Falk et al., 1973; Lavedan et al., 1989;
Palmer et al., 1976; Sanchez et al., 1974; Schedl et al., 1996; Strobel et
al., 1980). But, the question of the tissue speciﬁc functions has
remained unsolved. Another aspect that has never been addressed is
whether the iris defects are caused by an excess of the canonical splice
variant of Pax6 (Pax6-can) or by its alternative splice variant Pax6-5a
(Duncan et al., 2000; Singh et al., 2002). To confront these unresolved
issues, we utilized transgenic mice that overexpress Pax6 in a Cre-
dependent manner. These mice, designated JoP6 and JoP6-5a, carry a
ﬂoxed EGFP-stop cassette under the control of the β-actin/CMV fusion
promoter, followed by the coding sequence of either Pax6-can or
Pax6-5a and the β-galactosidase reporter gene (Fig. 4A and (Berger et
al., 2007)).
JoP6 and JoP6-5a embryos show widespread expression of EGFP
(Figs. 4B, F and (Berger et al., 2007)). Upon Tyrp2-Cre-mediated
recombination, both Tyrp2-Cre;JoP6 and Tyrp2-Cre;JoP6-5a expressed
β-galactosidase exclusively in the forebrain and eyes (Figs. 4C, G), the
latter mostly include the retinal margins (Figs. 4D, H). In perinatal
eyes, β-galactosidase staining was apparent in the developing iris and
CB (Figs. 4E–I) but only in a few cells of the RPE (not shown). This
pattern partly overlaps with Tyrp2-Cre transgene (Fig. 1F), possibly
due to a reduced activity of the Jo6/Jo6-5a transgenes in the RPE. Aer and the chicken β-actin promoter, a loxP-ﬂanked GFP-stop cassette, lacZ and the Pax6-
e, enabling the expression of Pax6 and β-galactosidase. (B, F) shows widespread GFP
-galactosidase staining of E12.5 Tyrp2-Cre;JoP6-5a (C) and Tyrp2-Cre;JoP6 (G) embryos
els C andG, respectively, showing positiveβ-galactosidase staining concentratedmostly
2-Cre;JoP6-5a (E) and Tyrp2-Cre;JoP6 (I) embryos demonstrating recombination in the
m, RPE. Scale bars: (A, E)=2 mm, (B, F)=1 mm, (C, D, G, H)=100 μm.
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ciliary epithelium demonstrated a 42%±14% and 27%±8% elevation
in adult Tyrp2-Cre;JoP6 and Tyrp2-Cre;JoP6-5a, respectively (n=4 and
3 eyes, pb0.05).
We next examined the phenotype of Tyrp2-Cre;JoP6 transgenic
mice. The most prominent feature resulting from Pax6-can over-
expression within the retinal margins was severe underfolding of the
CB (Figs. 5B, E and S2F). To obtain a three-dimensional view of the CB
and thus avoid variability due to plane of sectioning, we used SEM to
examine the CB of the Tyrp2-Cre;JoP6 mice as compared with control
littermates. This analysis revealed general atrophy of the Tyrp2-Cre;
JoP6 CB with a ﬂattened appearance of the folds (Fig. 5G). In contrast,
overexpression of the alternative splice variant 5a did not lead to
structural aberrations of the CB (Fig. S2E).
Normally, the CB is composed of a stroma and two epithelial layers
that start to fold at around the time of birth (Beebe, 1986). To
distinguish between these layers, we searched for markers with
differential expression. This analysis revealed that the stroma
expresses the VC1.1 epitope (Naegele and Barnstable, 1991), the
non-pigmented epithelium expresses CyclinD1 and Pax6, while the PE
expresses Pax6 but not VC1.1 or CyclinD1 (Figs. 5K, L). Assays for these
markers demonstrated that all CB layers of Tyrp2-Cre;JoP6 P2 eyes
were present but atrophic and barely folded (Figs. 5M, N).
To examine whether this phenotype is a result of enhanced
apoptosis, we performed a TUNEL assay on various embryonic and
postnatal stages (E14.5, E17.5, P2, P4 and P7). However, we could notFig. 5. Postnatal phenotype of Pax6 overexpression. (A–F) Semithin sections stained with
against Pax6 (K, M), CyclinD1 (L, N) and VC1.1 (L, N). Tyrp2-Cre;JoP6 adult mice exhibit decrea
transgenic mice (B, F, J) is markedly enlarged in comparison to control mice (A, D, H). Abbrev
K–O)=100 μm, (C–F)=20 μm. SEM magniﬁcation: G, I — ×500, H, J — ×200.detect any increase in the number of apoptotic cells between Tyrp2-
Cre;JoP6 and control littermates (not shown).
In addition to the CB phenotype, the iris sphincter of Tyrp2-Cre;
JoP6 mice was considerably enlarged, as can be seen in both eye
sections (Figs. 5B, F and S2C) and SEM images (Fig. 5J). In contrast, the
iris of Tyrp2-Cre;JoP6-5a mice was indistinguishable from controls
(Fig. S2B). Together, these results suggest that the dosage of Pax6-can
is directly related to the size of the sphincter muscle and that CB
development is greatly hampered by an exclusive excess Pax6-can.
The differential roles of Pax6-can and Pax6-5a splice variants in
iris development
As the deleted region in the Pax6ﬂox/+ allele includes exon 4–6, the
Pax6ﬂox/+;Tyrp2-Cremice are heterozygotes for both the Pax6-can and
Pax6-5a splice variants. Thus, their iris hypoplasia and the sphincter
and pupillary ruff defects could result from reduced dosage of either a
single splice variant or both. To determine the contribution of each of
these two splice variants to iris development, we utilized the JoP6 and
JoP6-5a mice to rescue the Pax6ﬂox/+;Tyrp2-Cre mutants, under the
assumption that genetic addition of each one of the two splice variants
separately can potentially expose splice variant-speciﬁc roles.
To examine the phenotype of Pax6ﬂox/+;Tyrp2-Cre;JoP6 and
Pax6ﬂox/+;Tyrp2-Cre;JoP6-5a triple transgenic mice, we examined
whole eyes (Figs. 6A–D) and sectioned irises (Figs. 6A'–D'). Quanti-
ﬁcation of the phenotype was performed based on two distincttoluidine blue, (G–J) SEM images, and (K–N) parafﬁn sections labeled with antibodies
sed size of the CB with reduced folding of the processes (B, E, I). The iris sphincter of the
iations: ciliary body, CB; iris, ir; le, lens; sphincter, S; toluidine blue, TB. Scale bars: (A, B,
Fig. 6. Distinct roles for the Pax6 alternative splice variants. (A–D) View of irises of adult eyes treated with pilocarpine and (A'–D') parafﬁn sections stained with hematoxylin-eosin
(H&E). The characteristic iris hypoplasia of Pax6ﬂox/+;Tyrp2-Cre mice (B) was rescued upon elevation of Pax6-can (C, C') and to a lesser extent, Pax6-5a (D, D'). (E) Quantitative
analysis of iris rescue (from 47% of normal iris length in Pax6ﬂox/+;Tyrp2-Cremice to 92% in Pax6ﬂox/+;Tyrp2-Cre;JoP6 and 73% in Pax6ﬂox/+;Tyrp2-Cre;JoP6-5a). Bars show standard
error, n=5, for wild-type eyes, n=6 for Pax6ﬂox/+;Tyrp2-Cre, n=8 for Pax6ﬂox/+;Tyrp2-Cre;JoP6 and n=7 for Pax6ﬂox/+;Tyrp2-Cre;JoP6-5a. ⁎pb0.005, ⁎⁎pb0.0005. The sphincter
muscle (arrowheads in panels A'–D'), which is nearly absent in Pax6ﬂox/+;Tyrp2-Cremutants (B'), appears normal in Pax6ﬂox/+;Tyrp2-Cre;JoP6 (C') but remains altered in Pax6ﬂox/+;
Tyrp2-Cre;JoP6-5a mice (D'). Abbreviations: cornea, co; iris, ir; lens, le. Scale bar (A–D)=1 mm, (A'–D')=100 μm.
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pupil margins (see Morphometric analysis section) and sphincter
appearance, scored between 0 and 2 (0=completely missing, 1=half
size or less, 2=normal size).Measurements of iris length revealed that
the iris hypoplasia was partially to fully corrected upon elevation of
either splice variants, with a lesser effect by Pax6-5a (from47±1.2% of
wild-type iris length in Pax6ﬂox/+;Tyrp2-Cre mice to 92±0.9% in
Pax6ﬂox/+;Tyrp2-Cre;JoP6 and to 73±1% in Pax6ﬂox/+;Tyrp2-Cre;JoP6-
5a, Figs. 6A–E). Multiple comparisons demonstrated that iris length of
all four groups was signiﬁcantly different with pb0.005 (see details in
Fig. 6E).
Sphincter appearance, which was scored 0 in Pax6ﬂox/+;Tyrp2-Cre
mutants (Fig. 6B') and 2 in controls (Fig. 6A'), showed signiﬁcant,
albeit variable improvement in Pax6ﬂox/+;Tyrp2-Cre;JoP6 mice (aver-
age score 1.00, ﬁve out of eight animals scoring 1 or above, Fig. 6C') but
was little changed in Pax6ﬂox/+;Tyrp2-Cre;JoP6-5a (average score 0.14,
one out of seven animals scoring 1, Fig. 6D'). The CB of Pax6ﬂox/+;
Tyrp2-Cre;JoP6 mice varied from a normal appearance to reduced
folding. Taken together, we concluded that both Pax6-can and Pax6-5aplay a role in iris growth but that Pax6-can is more potent and is
additionally involved in differentiation of the iris sphincter.
Discussion
Most biological systems seem to be insensitive to small changes in
gene dosage. This notion is in agreement with the observation that
most genetic diseases are inherited recessively ((Jimenez-Sanchez et
al., 2001) and reviewed in Barkai and Shilo (2007)). Nevertheless,
mutations in a growing number of transcription factors have been
reported to be pathological, even in the presence of one intact allele,
indicating dosage sensitivity (Jimenez-Sanchez et al., 2001).
Here, we investigated the phenotypes caused by varying levels of
the transcription factor Pax6 within iris and CB progenitors. Complete
loss of Pax6 resulted in the loss of both iris and CB, accompanied by
secondary changes in the lens and vitreous body. Heterozygosity for
Pax6 resulted in signiﬁcant hypoplasia of the iris with maturation
failure of the sphincter muscle, while the rest of the ocular sub-organs
remained intact. Finally, overexpression of the canonical, but not the
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and resulted in marked hypertrophy of the iris sphincter. Splice
variant-speciﬁc rescue experiments further revealed that both splice
variants contribute to iris growth, but only the canonical Pax6 is
involved in iris differentiation. These ﬁndings expose the strict
requirement of the anterior ocular structures for correct Pax6 dosage,
and assign a novel, splice variant-speciﬁc role for Pax6 in their
morphogenesis.
Pax6 expression in the RPE and retinal margins is essential for iris and
CB formation
Somatic inactivation of Pax6 in the RPE and retinal margins was
performed to determine the roles of Pax6 in the development of the
iris and CB pigmented cell types. This somatic mutation complements
a previous study in which Pax6 was ablated from the inner OC,
including the non-neuronal progenitors of the iris and CB (Davis-
Silberman et al., 2005; Marquardt et al., 2001). Both somatic
mutations resulted in a similar loss of iris and CB, thus supporting
the notion that Pax6 expression within the progenitors of the iris and
CB is required for their subsequent differentiation. Ablation of Pax6
from the inner OC resulted in differentiation defects of the neuroretina
(Marquardt et al., 2001; Oron-Karni et al., 2008), a phenotype thatwas
not detected in Pax6ﬂox/ﬂox;Tyrp-Cre mutants. Thus, the use of the
Tyrp-Cre line enabled us to focus on the non-neuronal progenitors and
avoid secondary impacts from the adjacent neuroretina. Another
major difference between these two Cre lines is their expression
pattern within the CB. Aside from the rare cells in the non-pigmented
layer that express the Tyrp-Cre transgene, most of the expression is
conﬁned to the pigmented CB, while α-Cre is expressed primarily in
the non-pigmented layer (Davis-Silberman et al., 2005). The ﬁnding
that the CB does not form upon ablation of Pax6 from either the
pigmented or non-pigmented layers of the CB is intriguing, and may
be related to a potential reciprocal inﬂuence of the two layers on each
other's morphogenesis.
Pax6 may be essential for CB and iris formation in several ways.
First, it may regulate the proliferation or survival of CB and iris
progenitors. This explanation, however, could not be supported by
speciﬁc assays aimed at detecting cell death or changes in prolifera-
tion (not shown). Alternatively, Pax6 may be involved in the
patterning of the OC. Intense Pax6 expression in the distal OC, in
comparison to weaker expression in the proximal retina and to no
expression in the proximal RPE, suggests that Pax6 deﬁnes the sub-
population of OC cells that become iris and CB. However, the early
expression of growth-arrest-speciﬁc 1 (Gas1), which is normally
conﬁned to the distal OC (Lee et al., 2001), was initiated in Pax6ﬂox/ﬂox;
Tyrp-Cremutants (E13.5) but gradually declined later in development
(E15.5, R.A. and R.A.-P., unpublished observations). This suggests that
despite an early deﬁnition of a non-neuronal areawithin the distal OC,
the subsequent stages of differentiation are dependent on Pax6
expression and are hampered in its absence.
In addition to the anterior structures' phenotype, Pax6ﬂox/ﬂox;Tyrp-
Cre mutants exhibited other symptoms that included an overall
decrease in the size of the eye and retina, lenticular aberrations and
invasion of the vitreous into the anterior chamber (Figs. 2F, O). In
addition, despite initial speciﬁcation of the RPE, we detected a marked
reduction in the pigment content of these cells (S.R., R.A.-P.,
unpublished observation). Several explanations can account for the
secondary ocular effects following Pax6 ablation from the RPE. The
reduction in eye and retina sizes, evident from E15.5 on (Fig. S1), can
result from malfunction of the mutant RPE (Raymond and Jackson,
1995). The lack of CB may interrupt the normal secretion of aqueous
humor (AH), causing a decline in IOP, known to be essential for
growth of the eye (Johnston et al., 1979). Moreover, the absence of CB
processes and a lack of AH probably allow the vitreous, normally
conﬁned to the back of the eye, to spread intomore anterior zones; theabsence of normal compartmentalization may account for the
observed lens phenotype (Lovicu et al., 2004). Taken together, these
ﬁndings reveal a pivotal role for Pax6 in the development of the iris
and CB and demonstrate the importance of the pigmented epithelium
and derived anterior structures to normal eye morphogenesis.
A high dosage of Pax6 is essential for sphincter muscle and pupillary
ruff formation
The smoothmuscles of the iris arise from the rims of the OC, which
have an atypical, non-mesodermal origin (Nussbaum, 1901; Szili,
1901). Our data raise the possibility that Pax6 is involved, either
directly or indirectly, in the transcription of myogenic factors. We have
previously found that somatic deletion of one allele of Pax6 from the
inner layer of the OC leads to a delay in the formation of the iris
musculature (Davis-Silberman et al., 2005). This ﬁnding may
potentially explain the atrophy of the sphincter: fewer cells are
committed to a muscle fate, hence the end organ is smaller. However,
lack of expression of the sphincter-speciﬁc marker Caveolin3 indicates
that later processes of differentiation and maturation might be
sensitive to Pax6 dosage as well. Pax3 and Pax7 are the Pax genes
associated thus far with myogenesis. As Pax3 expression was detected
in the avian iris (Jensen, 2005), it would be of interest to resolve the
speciﬁc roles of each of the Pax genes in myogenesis of the
mammalian iris.
Pax6ﬂox/+;Tyrp2-Cremice exhibit a complete lack of pupillary ruffs
(Fig. 3F, inset) — small bridges that surround the pupil margins,
created by folding of the iris PE over the sphincter. The function of
these structures is currently speculative, but changes in their
morphology have been shown to be associated with sphincter atrophy
(Sihota et al., 2004). Thus, the sphincter atrophy seen in Pax6ﬂox/+;
Tyrp2-Cre mutants may be secondary to iris pigmented epithelium
defects.
Different roles for Pax6-can and Pax6-5a in the developing iris and CB
Rescue experiments performed by crossing Tyrp2-Cre;Pax6ﬂox/+
and JoP mice revealed that iris growth is mediated by both splice
variants of Pax6, while sphincter formation is solely dependent on
Pax6-can. Differential functioning of Pax6 splice variants has been
previously documented in invertebrate and vertebrate species. In ﬂies,
Notch signaling has been shown to promote eye growth through
Eyegone but not Eyeless, the ﬂy homologs of Pax6-5a and Pax6-can,
respectively (Dominguez et al., 2004). Overexpression of human
PAX6-5a, but not PAX6-can induce overgrowth of the eye in ﬂies. In
the developing brain, the effect of Pax6 on progenitor proliferation is
mediated by the two Pax6 splice variants, while only Pax6-can is
involved in brain patterning and differentiation (Haubst et al., 2004)
and in apoptosis (Berger et al., 2007). Different functions have been
reported for the two splice variants using loss- and gain-of-function
approaches. Finally, overexpression of Pax6-5a, but not Pax6-can, has
been found to induce a well-differentiated retina-like structure in the
developing chick eye (Azuma et al., 2005).
The normal appearance of Tyrp2-Cre;JoP6-5a, in contrast to the
pronounced CB and iris phenotype of the Tyrp2-Cre;JoP6-can eyes,
suggests that in contrast to other ocular tissues, neither the iris nor the
CB are sensitive to an elevation in Pax6-5a. However, currently, we
cannot exclude the possibility that different expression levels of the
transgenes account for this phenotypic divergence.
Overexpression of Pax6-can results in abrogated development of the CB
In this paper we found that the CB is highly sensitive to an increase
in Pax6-can levels. Analysis of several typical markers revealed that
the initial speciﬁcation of the CB layers occurs but the undulating
processes are smaller or mostly missing (Figs. 5B, E, I). This could be
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dosage hampers aspects of cell proliferation ormaintenance. Indeed, it
has been shown that overexpression of Pax6-can leads to decreased
proliferation and enhanced apoptosis of cortical progenitors (Berger
et al., 2007). As a result, the overall thickness of the cortex was
signiﬁcantly reduced, although the correct positioning of the layers
was not affected. Nonetheless, altered proliferation or increased cell
death were not detected in Tyrp2-Cre;JoP6 mutants (E14.5, E17.5, P2,
P4, P7; not shown). This suggests that the source of the reduction in
tissue size is an initial decrease in the number of CB progenitors,
perhaps in favor of iris progenitors. If so, one can speculate that the
high Pax6 dosage in Tyrp2-Cre;JoP6 drives the anterior progenitors to
adopt an iris, rather than CB fate.
An alternative explanation for the CB phenotype is that the excess
Pax6 interrupts the normal process of folding. The question of how CB
processes fold has been studied for the last 50 years but has yet to be
fully elucidated. It is generally believed that IOP physically drives the
folding of the CB, either directly or indirectly by affecting cell
proliferation (Bard and Ross, 1982; Johnston et al., 1979; Reichman
and Beebe, 1992; Stroeva, 1967 and reviewed in Beebe (1986); Napier
and Kidson (2007)). IOP in the adult eye is generated by a constant
secretion of AH by the CB. In embryos, however, IOP is assumed to be
produced by growth of the vitreous. Nevertheless, studies in chicks
have demonstrated that the CB begins to acquire properties of
secretory epithelium a few days prior to its folding, suggesting that
it may be responsible for IOP generation at embryonic stages as well
(Porte et al., 1968 and reviewed in Beebe (1986)). If this scenario is
also true for mammals, the excess dosage of Pax6 in CB progenitors
could conceivably interrupt the early molecular events that lead to its
future folding.
To conclude, our studies demonstrate tissue speciﬁc roles for Pax6
in iris and CB development.We found that Pax6 is fundamental for the
genesis of both sub-organs and that Pax6 haploinsufﬁciency affects
iris growth and differentiation. In addition, the Pax6 splice variants do
not have equivalent biological activities. Pax6-can has a unique
function in sphincter formation, and can inhibit CB development upon
overexpression. Futurework is required to determine the downstream
targets of Pax6 that mediates its effect on the differentiation of the
pigmented, muscle and CB cell types of the eye.
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